ResearcherMedical College of WisconsinNo recent work listed
Emily P. Vonderhaar
Matched on ORCID iD 0000-0002-1158-7252; OpenAlex author ID A5078174437. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper
Papers 3
- STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer. Co-author DOI 10.1016/j.jcmgh.2021.01.018↗
- STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models. Co-author DOI 10.1186/s40425-019-0573-5↗
- Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/labinvest.2016.146↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michael B. Dwinell · 3 shared papers, 2017–2021 · strength 0.30
- Paper STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic C… DOI 10.1016/j.jcmgh.2021.01.018↗
- Paper STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models. DOI 10.1186/s40425-019-0573-5↗
- Paper Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. DOI 10.1038/labinvest.2016.146↗
- Jill A. Gershan · 1 shared paper, 2019 · strength 0.10
- Weiqing Jing · 1 shared paper, 2019 · strength 0.10
- Rosa F. Hwang · 1 shared paper, 2017 · strength 0.06
- Alexander Craig Mackinnon · 1 shared paper, 2017 · strength 0.06
- Ishan Roy · 1 shared paper, 2017 · strength 0.06
- Janusz Franco‐Barraza · 1 shared paper, 2017 · strength 0.06
- Noah P. Zimmerman · 1 shared paper, 2017 · strength 0.06
- Douglas B. Evans · 1 shared paper, 2017 · strength 0.06
- Edna Cukierman · 1 shared paper, 2017 · strength 0.06
- Susan Tsai · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.